Drugs used in the treatment of Neurofibromatosis help regulate abnormal cell proliferation and reduce tumor size. They are often used when surgery is not possible or when tumors cause severe symptoms.
Neurofibromatosis Drugs Market Size and Growth Outlook (2026–2034)
The global Neurofibromatosis Drugs Market size is projected to reach US$ 12.34 billion by 2034 from US$ 3.45...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek